In this episode of the GU Cast Podcast, Declan Murphy interviews Dr. Bishal Gyawali about Common Sense Oncology (CSO), an organization dedicated to promoting more meaningful outcomes in cancer care. They discuss CSO's mission to focus on patient-centered results like survival and quality of life, rather than just regulatory approval or marginal improvements in progression-free survival. Dr. Gyawali highlights the problem of misrepresented clinical trial results in the media, which often gives false hope to patients. The conversation explores how clinical trials are communicated and interpreted, emphasizing the need for accurate and ethical reporting to ensure patients receive realistic expectations about treatments. Dr. Gyawali shares insights into CSO's efforts to improve evidence generation, interpretation, and communication within the oncology field, involving stakeholders like regulators, payers, and journals to drive change.
Sign in to continue reading, translating and more.
Continue